Phathom Pharmaceuticals principal accounting officer Robert Breedlove resigns, effective Dec. 4, 2026
PHAT•Phathom Pharmaceuticals vice president of finance and principal accounting officer Robert Breedlove will resign effective Dec. 4, 2026. He notified the company on Nov. 12, and the resignation did not stem from disagreements over operations, policies or practices.
1. Resignation announced
Robert Breedlove, Phathom Pharmaceuticals’ vice president of finance and principal accounting officer, will resign effective Dec. 4, 2026. He notified the company on Nov. 12; the resignation did not stem from disagreements over operations, policies or practices.




